Knoxville Biz Ticker: Knoxville Entrepreneur Center launches Made for Knoxville campaign
The Knoxville News-Sentinel 3 hrs ago Knoxville News Sentinel
Knoxville Entrepreneur Center launches Made for Knoxville campaign
“Made for Knoxville” is a print and social media campaign and storytelling website initiated by the Knoxville Entrepreneur Center to elevate awareness of Knoxville’s diverse entrepreneurial ecosystem ranging from “solo-preneurs,” makers, growth stage tech companies, investors, and established institutions.
Made for Knoxville shines the light on the big wins, everyday hustles, and ongoing challenges that our entrepreneurial ecosystem faces in unprecedented times - through an incredible collection of original interview videos, profiles of nearly one hundred entrepreneurs, and original blog articles by Knoxville legend Jack Neely.
Search jobs 19-May-2021 IcanoMAB Announces a Novel IL-18 Signaling Blocker (anti-IL-1R7) Ready for Development for the Treatment of the Cytokine-Release-Syndrome in Late-stage Covid-19
IcanoMAB Announces a Novel IL-18 Signaling Blocker (anti-IL-1R7) Ready for Development for the Treatment of the Cytokine-Release-Syndrome in Late-stage Covid-19
Positive regulatory advice received for development plan to provide POC in late-stage COVID-19 patients
Additional opportunities in indications related to Cytokine-Release Syndrome, e.g., ARDS, MAS and acute inflammatory diseases
Pre-clinical proof-of-concept recently published with Charles Dinarello, University of Colorado, Denver
Partner discussions in preparation to exploit full therapeutic potential
POLLING, Germany, May 17, 2021 / B3C newswire / IcanoMAB, a privately-funded biotech company focusing on the pre-clinical and clinical development of novel precision antibodies for the
DNA Explainer: What is Line of Treatment for COVID? Why plasma therapy is now out of it?
The ICMR has clinically dropped convalescent plasma therapy treatment for patients suffering from COVID-19 from its newly revised guidelines. (Image Source: Reuters)
Updated: May 18, 2021, 12:48 PM IST
In a major development, the Indian Council of Medical Research (ICMR) has clinically dropped convalescent plasma therapy treatment for patients suffering from COVID-19 from its newly revised guidelines.
The decision of removing this treatment from the Line of treatment arrived after medical experts and scientists raised concerns against this practice. ICMR had permitted off-label use of convalescent plasma to treat COVID-19 patients in its revised guidelines on April 22, but now they have pulled it back.